Free Trial
NASDAQ:CAPS

Capstone Therapeutics (CAPS) Stock Price, News & Analysis

Capstone Therapeutics logo
$1.44 -0.22 (-13.25%)
As of 08/1/2025 04:00 PM Eastern

About Capstone Therapeutics Stock (NASDAQ:CAPS)

Key Stats

Today's Range
$1.29
$1.69
50-Day Range
$1.36
$1.94
52-Week Range
$1.29
$16.18
Volume
177,609 shs
Average Volume
90,559 shs
Market Capitalization
$230.40 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

Michael Parker
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
A capstone project
Capstone Holding Corp. (J7W.F)
See More Headlines

CAPS Stock Analysis - Frequently Asked Questions

Capstone Therapeutics' stock was trading at $2.40 on January 1st, 2025. Since then, CAPS shares have decreased by 40.0% and is now trading at $1.44.

Capstone Therapeutics (CAPS) raised $5 million in an initial public offering (IPO) on Thursday, March 6th 2025. The company issued 1,250,000 shares at $4.00 per share.

Capstone Therapeutics's lock-up period expires on Tuesday, September 2nd. Capstone Therapeutics had issued 1,250,000 shares in its initial public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CAPS
CIK
887151
Web
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
1.14
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$44.88 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($19.40) per share
Price / Book
-0.07

Miscellaneous

Outstanding Shares
160,000
Free Float
90,000
Market Cap
$230.40 thousand
Optionable
N/A
Beta
-0.80
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:CAPS) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners